Soft Tissue Allograft Market to grow with a CAGR of 7.40%
Increasing
healthcare infrastructure and a supportive regulatory environment are the major
drivers for the Global Soft Tissue Allograft Market.
According
to TechSci Research report, “Global Soft Tissue Allograft Market Industry
Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, Global Soft Tissue Allograft
Market has valued at USD 4.80 billion in 2022 and is anticipated to witness an
impressive growth in the forecast period with a CAGR of 7.40% through 2028. This
can be due to collaborations and partnerships among leading companies with a
diverse approach to merge the expertise of individual companies and to
strengthen their position in the market.
Minimally invasive techniques are indeed a
significant driver for the global soft tissue allograft market. Minimally
invasive procedures have gained popularity in various medical specialties, and
soft tissue allografts play a crucial role in supporting these less invasive
approaches. Patients undergoing minimally invasive surgeries often experience
improved outcomes, including shorter hospital stays, reduced scarring, and
faster return to normal activities. Soft tissue allografts contribute to these
benefits by promoting tissue repair and regeneration. Many orthopedic and
sports medicine procedures have transitioned to minimally invasive techniques,
such as arthroscopy. Soft tissue allografts are commonly used in these
procedures for ligament and tendon repairs, minimizing tissue disruption. In
dentistry, minimally invasive techniques are employed for procedures like gum
grafting and ridge augmentation. Soft tissue allografts are used to support
these less invasive approaches, improving patient comfort and outcomes.
Browse over XX market data Figures and spread through 110 Pages and an
in-depth TOC on "Soft Tissue Allograft Market”
Soft tissue allografts are utilized in knee
surgery to repair osteochondral defects, torn menisci, and weak ligaments.
Donor screening, laboratory testing, and tissue preparation make up the
three-stage safety screening procedure for sterile tissue allografts. In a
variety of operations, soft tissue allografts made up of bone, tendons,
cartilage, skin, heart valves, and veins are employed. One million soft tissue
allografts are transplanted yearly in the United States thanks to this
effective method that has been around for more than 150 years.
In
July 2022, the quadricep tendon has been added to the AlloConnex range of
tendons, ligaments, and fascia by AlloSource, one of the leading allograft
providers in the United States. AlloSource develops cutting-edge cellular and
tissue allografts to assist surgeons in healing their patients. Recently, it
has become more common to repair ligaments using a quadricep tendon.
AlloSource's AlloConnex quadricep tendon, which is offered with or without the
bone block for different surgical approaches, is a reliable solution for
cruciate ligament surgeries. A wide range of operations that surgeons carry out
are supported by the AlloConnex tendon and ligament portfolio. In addition to
the novel quadricep tendon, the AlloConnex portfolio of specialized allografts
also includes the patellar ligaments, Achilles, anterior tibialis, gracilis,
peroneus longus, posterior tibialis, and semitendinosus tendons. The tendon
supply offered by AlloSource consists of single strand, double strand, and
pre-shaped variants.
Product safety and quality concerns are significant
challenges in the global soft tissue allograft market. Ensuring the safety and
quality of allograft tissues is paramount to protect the health and well-being
of patients who receive these grafts. To minimize the risk of disease
transmission, rigorous screening and testing protocols are applied to potential
tissue donors. Donors are evaluated for medical history, lifestyle factors, and
infectious disease markers. Challenges arise when a donor's medical history is
incomplete or when new infectious diseases emerge. Ensuring that allograft
tissues are free from infectious agents is critical. Donor tissues are tested
for viruses, bacteria, and other pathogens. However, the risk of false
negatives or emerging infectious diseases remains a concern. The processing of
allograft tissues must adhere to strict quality control standards to maintain
tissue integrity and function. Any deviations or errors during processing can
compromise the quality and safety of the grafts.
Global Soft Tissue Allograft Market segmentation is
based on
Type, Application, End User, Region and Company
Based on Type, Global Soft Tissue Allograft Market
is segmented into Amniotic Allograft, Cartilage, Collagen Allograft, Dental
Allograft, Meniscus Allograft, Tendon Allograft. A meniscus allograft is a
medical graft or transplantation of the meniscus, a C-shaped cartilage
structure located in the knee joint, taken from a cadaveric (deceased) donor,
and transplanted into a recipient's knee. The meniscus allograft is used to
replace a damaged or surgically removed meniscus in individuals with knee
injuries or conditions. The meniscus is a crucial structure in the knee joint,
consisting of two wedge-shaped pieces of cartilage—known as the medial meniscus
and lateral meniscus—situated between the femur (thigh bone) and tibia (shin
bone). Its primary function is to act as a shock absorber, distribute load across
the knee, and provide stability. Meniscus allograft transplantation is
considered when a patient has a damaged or surgically removed meniscus due to
injuries, degeneration, or prior surgeries. Common indications include
irreparable meniscal tears, meniscectomy (partial or complete removal of the
meniscus), or congenital absence of the meniscus.
Based on Region, North America dominated the Global Soft Tissue Allograft Market.
North America has an aging population. As people age, they are more prone to musculoskeletal
problems and injuries. Soft tissue allografts are frequently used in orthopedic
and sports medicine procedures to address these issues. North America has a
well-established and robust regulatory framework for the approval and
distribution of medical devices, including soft tissue allografts. This helps
ensure the safety and quality of these products, giving healthcare providers
confidence in using them. The region has relatively well-structured healthcare
reimbursement systems that often cover soft tissue allograft procedures. This
makes these treatments more accessible to patients and financially viable for
healthcare providers. North America is home to several major market players in
the soft tissue allograft industry. These companies have a strong presence in
the region, offer a wide range of products, and have established relationships
with healthcare providers.
Asia-pacific region to fastest growth in
the Global Soft Tissue Allograft Market. The APAC region has a rapidly aging population,
which is prone to musculoskeletal issues, injuries, and dental problems that
often require soft tissue allograft procedures. The demand for these procedures
has been on the rise due to the demographic shift. Many APAC countries have
been increasing their healthcare budgets and investing in healthcare
infrastructure, leading to improved access to surgical procedures and soft
tissue allografts. A growing middle-class population in APAC countries has
increased access to healthcare services and elective surgical procedures,
contributing to the demand for soft tissue allografts. The APAC region has seen
significant growth in dental procedures, including implant placements and
periodontal surgeries, which often involve the use of soft tissue allografts.
Some
of the major companies operating in the Global
Soft Tissue Allograft Market include:
- CONMED
Corporation
- XTANT
MEDICAL
- ALONSOURCE
GROUP
- Becton
& Dickinson Co.
- Arthrex,
Inc
- Integra
LifeSciences
- Stryker
Corporation
- Institute
Straumann AG
- Organogenesis
Inc.
Download Free Sample Report
Customers can also request
10% free customization on this report
“Certain areas, particularly in
North America, are projected to exert significant demand for Soft Tissue
Allograft. The growth in the competitive landscape and the presence of
well-established companies in the market, committed to enhance the overall
wellbeing of people each year, are expected to contribute to a remarkable
growth of the Global Soft Tissue Allograft Market in the forecast period,"
said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based Global management consulting firm.
Soft Tissue Allograft
Market – Global Industry Size, Share, Trends, Opportunity, and Forecast,
2018-2028 Segmented by Type (Amniotic Allograft, Cartilage, Collagen Allograft, Dental Allograft, Meniscus Allograft, Tendon Allograft), by Application
(Dentistry, Orthopedic, Wound
Care) by End-User (Hospitals & Clinics, Ambulatory Care Centers, Others),
by region, and Competition evaluated
the future growth potential of Global Soft Tissue Allograft Market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide innovative market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Soft Tissue Allograft Market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com